Tag Archives: Biomet

Featured Stories

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Medtronic Settles Charges Over Kickbacks To Doctors

Medical device giant, Medtronic Inc., is settling charges over kickbacks to doctors. The firms just agreed to pay $23.5 million to settle claims it paid physicians kickbacks in exchange for their use of its pacemakers and defibrillators, according to a U.S. Justice Department announcement yesterday. The company was accused of seeking ...

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Whistleblower Wins Retaliation - Canaveral National Seashore

Whistleblower Wins Retaliation Lawsuit

A whistleblower who reported misconduct at Canaveral National Seashore has won a retaliation ruling against the U.S. Department of Interior, Florida Today reports.

Read More

Biomet Faces New Lawsuit over Metal-on-Metal Hip Implant

Biomet Faces New Lawsuit over Metal-on-Metal Hip Implant

Biomet is facing a new lawsuit alleging that its metal-on-metal hip implant is to blame for a New York woman’s injuries. The plaintiff is a 61-year-old woman who was implanted with the Biomet M2a Magnum Hip Replacement System in her … Continue reading

Posted in Defective Medical Devices, Metal Hip Implants | Tagged , , , , , , , , |

Biomet Probation Extended by a Year in Light of New Bribery Evidence

Biomet Probation Extended by a Year in Light of Evidence

The New York Times reports that Biomet’s federal probation was set to expire next week, but new evidence of foreign bribery has extended it by a year. During that time, the Justice Department will investigate the issue. Additionally, the Justice … Continue reading

Posted in Defective Medical Devices, Legal News | Tagged , , , , |

Brilinta May Prevent Heart Attacks But Can Raise Bleeding Risks

Brilinta Prevents Heart Attacks But Can Raise Bleeding

While clinical trial results for AstraZeneca’s heart drug Brilinta (ticagrelor) are positive, the trail showed bleeding risks with the blood-thinning drug. A 21,000-patient clinical trial showed Brilinta (ticagrelor) cuts heart attacks and strokes, but caused more bleeding, Reuters reports.

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.